APYX - Apyx Medical Corp

NYSE * Health Care * Health Care Equipment & Supplies

$3.88

$-0.08 (-2.02%)

About Apyx Medical Corp

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

APYX Key Statistics

Market Cap

$165.64M

0

P/B Ratio

11.39

EPS

$-0.27

Revenue Growth

+0.3%

Profit Margin

-0.2%

Employees

205

How APYX Compares to Peers

APYX has the fastest revenue growth among competitors
APYX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

#2

of 2

Growth Rank

#1

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
APYXN/A0%-
AMZN33.40%vs AMZN

Apyx Medical Corp Company Information

Headquarters
Florida; U.S.A
Website
apyxmedical.com
Sector
Health Care
Industry
Health Care Equipment & Supplies
Data Updated:
Ready to invest in APYX?

Commission-free trading available. Affiliate links.

APYX Lician Score

10% confidence
5.0/10
Neutral

APYX has a Lician Score of 5/10 (Average). The stock shows average characteristics across all dimensions.

value

5.0

growth

4.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates APYXacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

APYX Financial Snowflake

5-axis analysis across key investment dimensions

4.8/10

Neutral

35810Value5.0Growth4.0Quality5.0Momentum5.0Safety5.04.8/10
5.0

Value

4.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for APYX